bluebird bio is to ask regulators to restart clinical studies of its LentiGlobin for sickle cell disease, after an investigation concluded that a case of acute myeloid leukaemia (AML) was "very ...

Bluebird’s lead CAR-T cancer cell therapy idecabtagene vicleucel (ide-cel) was last year hit with an FDA refuse-to-file letter, which required additional data on chemistry, manufacturing and ...

If the procedure succeeds, the rewards will automatically get credited to your War Tycoon accounts. Shaun is the lead contributor on AppSpy and 148Apps, but sometimes pops up on Pocket Gamer just to ...